Key Insights

Highlights

Success Rate

97% trial completion (above average)

Published Results

52 trials with published results (37%)

Research Maturity

112 completed trials (79% of total)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

2.8%

4 terminated out of 142 trials

Success Rate

96.6%

+10.1% vs benchmark

Late-Stage Pipeline

28%

40 trials in Phase 3/4

Results Transparency

46%

52 of 112 completed with results

Key Signals

52 with results97% success

Data Visualizations

Phase Distribution

123Total
Not Applicable (36)
Early P 1 (3)
P 1 (15)
P 2 (29)
P 3 (23)
P 4 (17)

Trial Status

Completed112
Unknown11
Recruiting6
Terminated4
Not Yet Recruiting3
Withdrawn3

Trial Success Rate

96.6%

Benchmark: 86.5%

Based on 112 completed trials

Clinical Trials (142)

Showing 20 of 20 trials
NCT04886739Phase 2CompletedPrimary

CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea

NCT04275999Phase 2CompletedPrimary

Rosacea and Ivermectin

NCT07431476Phase 4CompletedPrimary

Brimonidine 0.33% for Rosacea-Related Facial Erythema

NCT06312813Phase 2RecruitingPrimary

Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea

NCT07410533Not ApplicableCompleted

Analysis of Factors Associated With the Efficacy of 595-nm Pulsed Dye Laser Treatment for Rosacea

NCT07296497Not ApplicableRecruitingPrimary

Acupuncture for Refractory Rosacea: A Study on Its Effectiveness and Safety

NCT06776445Phase 1CompletedPrimary

Efficacy and Safety of Different Dose Regimens of Gabapentin for Treating Erythema/Flushing in Rosacea: A Randomized Controlled Trial

NCT07290426Not ApplicableNot Yet RecruitingPrimary

Vbeam Pro Pulse Dye Laser for the Treatment of Vascular Conditions

NCT07250165Not ApplicableCompletedPrimary

Combined Therapy of 532-nm KTP and Microsecond 1064-nm Nd:YAG Laser for Rosacea

NCT03989492Not ApplicableCompletedPrimary

Role of the Sympathetic Nervous System in Rosacea

NCT05815511Not ApplicableCompletedPrimary

Clinical Trial to Evaluate the Effect of a Probiotic Mixture on the Rosacea Evolution

NCT05928169Recruiting

Determinants of Chronic Inflammatory Skin Disease Trajectories

NCT07046039Completed

The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia.

NCT04108897Early Phase 1Active Not RecruitingPrimary

Analysis of the Microbiome in Rosacea

NCT06915636Not ApplicableCompletedPrimary

Comparative Study of Low-Energy 1064nm Laser and DPL in Rosacea Treatment

NCT06969300Not ApplicableCompletedPrimary

FMRF Combined With 30% SSA in the Treatment of Rosacea

NCT05045469Phase 2CompletedPrimary

Therapeutic Effects of Topical Herbal Medicine -Rhubarb Ointment on Rosacea

NCT06873087Phase 4CompletedPrimary

Changes in PACAP, CGRP, and VIP Levels in Rosacea Patients on Systemic Isotretinoin and Their Association with Erythema

NCT06582043Not ApplicableCompletedPrimary

Evaluation of the Efficacy and Tolerance of Two Cosmetic Products in Subjects With Rosacea

NCT06763367Not ApplicableNot Yet RecruitingPrimary

Clinical Evaluation and Study of the Efficacy of a Centella Asiatica-Infused Facial Mask on Discosmetic Dermatosis

Scroll to load more

Research Network

Activity Timeline